Diogo Teles

Diogo Teles

Auto-generated profile, based on publicly available information

Diogo Teles

Department of Biomedical Engineering, Columbia University, New York, NY, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 April 2018 in Nature
Verified
Journal Article
Closed access
PDF file
KRKacey Ronaldson-Bouchard
Kacey Ronaldson-Bouchard
SMStephen P. Ma
Stephen P. Ma
KYKeith Yeager
Keith Yeager
TCTimothy Chen
Timothy Chen
LSLouJin Song
LouJin Song
Gordana Vunjak-NovakovicGordana Vunjak-Novakovic
Gordana Vunjak-Novakovic

27 April 2022 in Nature Biomedical Engineering
Verified
Journal Article
Closed access
PDF file
KRKacey Ronaldson-Bouchard
Kacey Ronaldson-Bouchard
DTDiogo Teles
Diogo Teles
KYKeith Yeager
Keith Yeager
DTDaniel Naveed Tavakol
Daniel Naveed Tavakol
YZYimu Zhao
Yimu Zhao
Gordana Vunjak-NovakovicGordana Vunjak-Novakovic
Gordana Vunjak-Novakovic

6 September 2019 in Nature Protocols
Verified
Journal Article
Open access
PDF file
KRKacey Ronaldson-Bouchard
Kacey Ronaldson-Bouchard
KYKeith Yeager
Keith Yeager
DTDiogo Teles
Diogo Teles
TCTimothy Chen
Timothy Chen
SMStephen Ma
Stephen Ma
Gordana Vunjak-NovakovicGordana Vunjak-Novakovic
Gordana Vunjak-Novakovic
The application of tissue-engineering approaches to human induced pluripotent stem (hiPS) cells enables the development of physiologically relevant human tissue models for in vitro studies of development, regeneration, and disease. However, the immature phenotype of hiPS-derived cardiomyocytes (hiPS-CMs) limits their utility. We have developed a protocol to generate engineered cardiac tissues from hiPS cells and electromechanically mature them toward an adult-like phenotype. This protocol also provides optimized methods for analyzing these tissues’ functionality, ultrastructure, and cellular properties. The approach relies on biological adaptation of cultured tissues subjected to biomimetic cues, applied at an increasing intensity, to drive accelerated maturation. hiPS cells are differentiated into cardiomyocytes and used immediately after the first contractions are observed, when they still have developmental plasticity. This starting cell population is combined with human dermal fibroblasts, encapsulated in a fibrin hydrogel and allowed to compact under passive tension in a custom-designed bioreactor. After 7 d of tissue formation, the engineered tissues are matured for an additional 21 d by increasingly intense electromechanical stimulation. Tissue properties can be evaluated by measuring contractile function, responsiveness to electrical stimuli, ultrastructure properties (sarcomere length, mitochondrial density, networks of transverse tubules), force–frequency and force–length relationships, calcium handling, and responses to β-adrenergic agonists. Cell properties can be evaluated by monitoring gene/protein expression, oxidative metabolism, and electrophysiology. The protocol takes 4 weeks and requires experience in advanced cell culture and machining methods for bioreactor fabrication. We anticipate that this protocol will improve modeling of cardiac diseases and testing of drugs.

4 September 2020 in Lab on a Chip
Verified
Journal Article
Closed access
PDF file
ACAlan Chramiec
Alan Chramiec
DTDiogo Teles
Diogo Teles
KYKeith Yeager
Keith Yeager
AMAlessandro Marturano-Kruik
Alessandro Marturano-Kruik
JPJoseph Pak
Joseph Pak
Gordana Vunjak-NovakovicGordana Vunjak-Novakovic
Gordana Vunjak-Novakovic
In a novel, integrated platform, integration of human bone tumor and cardiac tissues improved predictive accuracy of linsitinib efficacy and safety. This platform mimicked clinical trial results, unlike other pre-clinical models.

2 June 2024 in Expert Opinion on Drug Discovery
Verified
Journal Article
Open access
DTDiogo Teles
Diogo Teles
BFBarry Fine
Barry Fine
Arrhythmias are disturbances in the normal rhythm of the heart and account for significant cardiovascular morbidity and mortality worldwide. Historically, preclinical research has been anchored in animal models, though physiological differences between these models and humans have limited their clinical translation. The discovery of human induced pluripotent stem cells (iPSC) and subsequent differentiation into cardiomyocyte has led to the development of new in vitro models of arrhythmias with the hope of a new pathway for both exploration of pathogenic variants and novel therapeutic discovery. The authors describe the latest two-dimensional in vitro models of arrhythmias, several examples of the use of these models in drug development, and the role of gene editing when modeling diseases. They conclude by discussing the use of three-dimensional models in the study of arrythmias and the integration of computational technologies and machine learning with experimental technologies. Human iPSC-derived cardiomyocytes models have significant potential to augment disease modeling, drug discovery, and toxicity studies in preclinical development. While there is initial success with modeling arrhythmias, the field is still in its nascency and requires advances in maturation, cellular diversity, and readouts to emulate arrhythmias more accurately.

19 August 2026 in Science Translational Medicine
Verified
Journal Article
Closed access
ACAlan G. Chramiec
Alan G. Chramiec
IBIlaria Baldassarri
Ilaria Baldassarri
EÖEce Öztürk
Ece Öztürk
DTDaniel Naveed Tavakol
Daniel Naveed Tavakol
MWMiranda C. Wang
Miranda C. Wang
Gordana Vunjak-NovakovicGordana Vunjak-Novakovic
Gordana Vunjak-Novakovic
For metastatic colonization to occur, disseminated tumor cells must survive, adapt to, and remodel distant microenvironments in an organ-specific manner. We established a human multitissue model of cancer spread, with engineered bone and lung linked by vascular flow containing circulating cancer cells. Parental MDA-MB-231 cells extravasated toward both tissues, remodeled their niches, and acquired transcriptional programs reflecting adaptation to the local microenvironment, particularly upon homing to bone. Tissue-specific colonization by the bone- and lung-tropic MDA-MB-231 derivatives was quantified in independently perfused bone or lung platforms. Consistent with in vivo behavior, bone-tropic cells showed stronger bone colonization than lung-tropic cells and induced more pronounced osteolysis. In contrast, lung-tropic cells caused greater epithelial disruption in lung tissue and only modest colonization of bone. Distinct patterns of tissue colonization and secreted factors demonstrate that this device recapitulates key features of organ-specific metastasis observed in vivo for this family of cell lines.